Non-melanoma Skin Cancer Clinical Trial
Official title:
Prognostic Value of RXR-α in Cutaneous Squamous and Basal Cell Carcinoma: An Immunohistochemical Study.
Vitamin D has a crucial role in cancer control and prevention.vitamin D receptor (VDR) and its heterodimer Retinoid X receptor (RXR) are equally important in the cell. This ligand (vitamin D) and receptors (VDR-RXR) complex together triggers downstream DNA damage response in the cell. Retinoid receptors are a superfamily of nuclear receptors. The preferred receptor that attaches to VDR is RXR, with its subunits α, β and γ. RXR α is more frequent in the skin than other tissues, while β occurs in internal organs and γ is frequently related to neural disorders. the investigator hopes to assess prognosis of SCC & BCC by using RXR-α biomarker & attempts to use it in the treatment.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04103658 -
NIR and Skin Cancer Margins
|
N/A | |
Completed |
NCT01053819 -
Can We Miss Pigmented Lesions in Psoriasis Patients?
|
Phase 4 | |
Recruiting |
NCT03767348 -
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab
|
Phase 2 | |
Recruiting |
NCT05429866 -
Immunological Variables Associated to ICI Toxicity in Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT02636569 -
Topical Chemoprevention of Skin Cancer Biomarkers
|
Phase 2 | |
Completed |
NCT02760160 -
Dietary Prevention of Photodamage in Skin With Grapes
|
N/A | |
Completed |
NCT02780934 -
Comparing Pressure Versus Simple Adhesive Dressing After Mohs Reconstruction
|
N/A | |
Completed |
NCT02872909 -
Randomized Comparison of Low and Conventional Irradiance PDT for Skin Cancer
|
N/A | |
Withdrawn |
NCT03327064 -
A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT00342407 -
The Incidence of Breast and Other Cancers Among Female Flight Attendants
|
||
Terminated |
NCT04410874 -
Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03693937 -
A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)
|
||
Completed |
NCT04334824 -
Hydrochlorothiazide and Risk of Skin Cancer
|
||
Recruiting |
NCT05878288 -
Deep sequencIng in Cutaneous Squamous CEll caRciNomas
|
Phase 2 | |
Completed |
NCT01359735 -
Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients
|
Phase 2 | |
Terminated |
NCT04348916 -
Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors
|
Phase 1 | |
Enrolling by invitation |
NCT05257486 -
Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx
|
||
Recruiting |
NCT06428721 -
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
|
N/A | |
Withdrawn |
NCT03757663 -
UV Dosimetry Feedback in NMSC Patients
|
N/A | |
Completed |
NCT04116983 -
DERM NMSC Validation Study
|